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Identification of hyaluronan as a crystal-binding molecule at specimens. Under nonpathological conditions, crystals
the surface of migrating and proliferating MDCK cells. are washed out unhindered with the urine. Interaction
Background. The adherence of calcium oxalate crystals to
of crystals with the tubular epithelium may lead to thethe renal tubule epithelium is considered a critical event in the
retention and accumulation of crystalline material in thepathophysiology of calcium nephrolithiasis. Calcium oxalate
monohydrate (COM) crystals cannot adhere to the surface of kidney and eventually to the development of a renal stone
a functional Madin-Darby canine kidney (MDCK) monolayer, [1–3]. The mechanisms by which crystals become associ-
but they bind avidly to the surface of proliferating and migrat-
ated with the renal tubule epithelium are poorly under-ing cells.
stood and are difficult to study in human subjects. There-Methods. To identify crystal-binding molecules (CBMs) at
the surface of crystal-attracting cells, we applied metabolic fore, experimental models, including theoretical [1, 3],
labeling protocols in combination with differential enzymatic cell culture [4–6], and animal [7, 8] models, have been
digestion and gel filtration, which was compared with [14C]COM
employed to reconstruct the transitory and spatial eventscrystal binding and confirmed by confocal microscopy.
contributing to the pathogenesis of renal stone forma-Results. The indication that hyaluronan [hyaluronic acid
(HA)] might act as a CBM in subconfluent cultures came from tion. Although calcium nephrolithiasis is associated with
studies with glycosaminoglycan (GAG)-degrading enzymes. epithelial injury, it is not clear whether the stone-forming
Subsequently, metabolic-labeling studies revealed that hyal-
process is damaging to the renal epithelium or whetheruronidase cleaved significantly more radiolabeled glycoconju-
epithelial injury should be regarded as an initiating fac-gates from crystal-attracting cells than from cells without affin-
ity for crystals. During wound repair, crystal binding could be tor. Earlier, we found that the affinity of Madin-Darby
prevented by pretreating the healing cultures with hyaluronate canine kidney (MDCK)-I cells for calcium oxalate crys-
lyase, an enzyme that specifically hydrolyzes HA. Binding to
tals is influenced by the developmental stage of theseimmobilized HA provided evidence that COM crystals physi-
cells. Crystals adhered avidly to the surface of proliferat-cally can become associated with this polysaccharide. Finally,
confocal microscopy demonstrated that fluorescently labeled ing cells in subconfluent cultures but hardly to growth-
HA binding protein (HABP) adhered to the surface of prolifer- arrested cells in confluent monolayers [9, 10]. From these
ating cells in subconfluent cultures as well as to cells involved
findings, it was speculated that a functional epitheliumin closing a wound, but not to cells in confluent monolayers.
is nonadherent to crystals. After intact monolayers wereConclusions. These results identify HA as binding molecule
for COM crystals at the surface of migrating and proliferating mechanically injured, the epithelium showed a remark-
MDCK cells. able capacity to heal and re-establish its functionality
[9]. Cells at the border of the wounds stretched, prolifer-
ated, and migrated into the denuded areas until the
Urine is frequently supersaturated with respect to cal- wounds were closed. During this process, crystals selec-
cium salts, such as calcium phosphate and calcium oxalate. tively adhered to the surface of those cells that were
This oversaturated state occasionally leads to the sponta- involved in wound healing. Soon after the epithelial bar-
neous nucleation of crystals as observed in most urine rier integrity was re-established, the epithelium regained
its nonadherent properties [9]. These observations are
in agreement with the idea that crystal retention is pre-Key words: nephrolithiasis, calcium oxylate monohydrate crystals,
MDCK, epithelial injury, hyaluronan. ceded by epithelial injury. The selective adherence of
crystals to cells in developing epithelia suggests that such
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METHODS 1.5 CaCl2, 0.5 MgCl2, 8.3 d-glucose, 4 l-alanine, 5 Na
acetate, 6 urea, and 10 mg/mL bovine serum albumin,Cell culture
pH 7.4, 310 to 320 mOsm/kg H2O. Both solutions wereMadin Darby canine kidney-I cells were kindly pro- equilibrated for 20 minutes with 5% CO2 in air at 378Cvided by Professor Dr. G. van Meer (Laboratory for Cell and were adjusted to pH 6.7 (CCD-A) or pH 7.4 (CCD-B).
Biology and Histology, Amsterdam Medical Center, Am- The cells were washed and preincubated for 10 minutes
sterdam, The Netherlands) [11]. Routinely, the cells were with calcium-containing phosphate-buffered saline (PBS)
cultured in plastic culture flasks and were replated weekly. to be replaced by CCD-A in the apical compartment
For crystal binding studies, cells were seeded at a plating and CCD-B in the basal compartment. Subsequently,
density of 1 3 106 cells on 24 mm polycarbonate porous the crystal suspension was vigorously pipetted, and 50 mL
filter inserts (Corning Costar, Badhoevedorp, The Nether- were distributed homogeneously on top of the cells (16
lands) and cultured for the indicated periods of time in mg/cm2). After an incubation period of 60 minutes, the
Dulbecco’s modified minimal essential medium (GIBCO, monolayers were rinsed extensively to remove all nonas-
Grand Island, NY, USA) supplemented with 10% fetal sociated crystals. The filter inserts were cut out with a
calf serum (PAA Labs, Linz, Austria). Culture medium scalpel and transferred to a scintillation vial. To extract
was refreshed every other day. The cells were routinely radioactivity, 1 mL of 1 M perchloric acid was added,
checked for mycoplasm contamination and were found and the amount of radioactivity was counted in a liquid
to be negative. scintillation counter (Packard, Meriden, CT, USA). The
amount of associated crystals was calculated from the
Preparation of CaOx crystals dpm/filter and was usually expressed in mg/cm2.
A solution of radioactive sodium oxalate was prepared
Wounds made in confluent monolayersby adding 1 mL of 0.37 MBq/mL [14C]oxalic acid (Amer-
To study the effect of epithelial damage on crystalsham Int. plc., Buckinghamshire, UK) to 0.25 mL of 200
adherence, MDCK monolayers were injured at sevenmmol/L sodium oxalate. A calcium chloride solution was
days after seeding. Strips of cells were scraped off fromprepared by adding 0.25 mL of 200 mmol/L calcium chlo-
the monolayer using the tip of a sterile 5 mL tissue cultureride to 8.5 mL distilled water. After mixing the two solu-
pipette. Two perpendicular scratches created a relativelytions at room temperature (final concentration 5 mmol/L
large cross-shaped wound with an approximate area offor both calcium and oxalate), radiolabeled CaOx crys-
100 to 150 mm2, equal to about one third of the totaltals were formed immediately. The crystal suspension
filter area. After injury, the process of wound healingwas allowed to equilibrate for three days and was then
was monitored by light and confocal microscopy and bywashed three times with (sodium and chloride-free) CaOx
monitoring transepithelial electrical resistances (TERs).saturated water and was resuspended in 5 mL of this
solution (1.46 mg CaOx crystals/mL). Crystal–cell interaction by confocal laser
scanning microscopyEnzyme treatment
After incubation with calcium oxalate monohydrateCells were treated with enzymes dissolved in Dulbecco’s
(COM) crystals, the cultures were washed extensivelymodified Eagle’s medium (DMEM) at 378C. Hyaluroni-
with CaOx-saturated PBS to remove all nonadhereddases included hyaluronoglucosaminidase (EC 3.2.1.35),
crystals. The cells were fixed in 3.7% formaldehyde for
25 U/mL, pH 5.5, for one hour, and hyaluronate lyase 15 minutes and were then permeabilized for 15 minutes
(EC 4.2.2.1) 5 U/mL, pH 5.5, for one hour. Heparinase with 70% ethanol. Subsequently, the inserts were washed
included heparitinase I (EC 4.2.2.8) 0.2 U/mL, pH 7.4, with PBS, cut out, and incubated for 15 minutes with 5
for four hours. Chondroitinase was chondroitin ABC lyase mg/mL fluorescein isothiocyanate-conjugated phalloidin
(EC 4.2.2.4) 0.1 U/mL, pH 7.4, for one hour. All enzymes (FITC-phalloidin) at the apical site, washed two times
were derived from Sigma-Aldrich Chemie (Zwijndrecht, for three minutes with PBS and mounted in Vectashield
The Netherlands). (Vector Laboratories, Burlingame, CA, USA). Images
were made with a Zeiss LSM 410 laser-scanning confocalCrystal binding
microscope (Zeiss, Oberkochen, Germany). A 488 nm
The apical compartment received a buffer (CCD-A) Ar-laser was used to excitate the FITC-phalloidin. COM
representative for the tubular fluid and contained (in crystals were detected by their reflection of the 633 nm
mmol/L) the following: 140 NaCl, 5 KCl, 1.5 CaCl2, 0.5 (red) Kr-laser.
MgCl2, 50 urea, pH 6.6, 310 to 320 mOsm/kg H2O. This
Hyaluronan staining using hyaluronic acidsolution was saturated with CaOx. To the basal compart-
binding proteinment, representative for renal peritubular capillary plasma,
a buffer (CCD-B) was added that contained (in mmol/L) Biotinylated hyaluronic acid binding protein (bHABP;
400763-1) was obtained from Seikagaku Inc. (Brunschwigthe following: 124 NaCl, 25 NaHCO3, 2 Na2HPO4, 5 KCl,
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Chemie, Amsterdam, The Netherlands) and fluorescent crystals were removed by extensive washings, and the
remaining adhered crystals were dissolved in 0.5 mL 1 Navidin D (A-2001) from Vector Laboratories. Cells were
fixed in 5% glacial acetic acid, 10% formalin, and 70% HCl. After neutralization with 0.5 mL 1 N NaOH, the
amount of surface-associated radioactivity was deter-ethanol (vol/vol), and were washed and incubated over-
night at 48C with 5 mg/mL bHABP in 3% bovine serum mined in a scintillation counter.
albumin (BSA). The bHABP bound to cell surface hya-
luronan, which was visualized by confocal microscopy
RESULTS
after a one-hour incubation in avidin-FITC (1:250) and
Effect of GAG-degrading enzymes on [14C]COMembeddeing into Vectashield. To monitor the location
crystal–cell interactionof the cells in the sample, the nuclei were counterstained
with propidiumiodide (which appears red in the images). Calcium oxalate monohydrate crystals adhere to the
surface of proliferating MDCK-I cells in subconfluent
Metabolic labeling cultures, but not to epithelial sheets in which neighboring
cells are connected to each other by functional tight junc-Glucosamine is a precursor for sugar units, including
N-acetylglucosamine (GlcNAc). MDCK cells were seeded tions (Fig. 1). This was exploited here to study the pres-
ence or absence of cell surface-associated CBMs [9, 10].at a concentration of 1 3 106 per insert on porous mem-
branes and cultured for two or seven days. At these time The possible involvement of glycosaminoglycans (GAGs)
as binding molecules for COM crystals at the cell surfacepoints, the growth substrates, respectively, contained
0.96 6 0.2 3 106 cells (subconfluent) and 3.99 6 0.3 3 106 was explored by measuring the effect of GAG-degrading
enzymes on crystal binding. Subconfluent crystal-attract-cells (confluent). Cells were preincubated for 18 hours
in modified DMEM with a reduced glucose content (1 ing cultures were treated with chondroitinase ABC and
heparinase III to cleave chondroitin sulfate (CS) and hep-mg/mL). Subsequently, this culture medium was replaced
by the same medium containing 2 mCi/mL [3H]glucos- aran sulfate (HS) chains from cell surface-associated pro-
teoglycans. In contrast to heparinase, treatment with chon-amine (Amersham), and the cells were incubated for an
additional period of 24 hours. To monitor the enzyme- droitinase ABC significantly reduced the level of crystal
binding (Table 1). Crystal binding was also reduced afterinduced release of HA fragments, MDCK cells cultured
on permeable supports were [3H] labeled with glucos- treating the cells with hyaluronidase (Hdase), an enzyme
that hydrolyzes hyaluronan (HA), a GAG that is not co-amine. Spent medium (conditioned medium), cell ho-
mogenates solubilized in 500 mL 4 mol/L guanidine/2% valently linked to proteins. It should be mentioned here,
however, that CS and HA both are substrates for chon-Triton X-100/0.05 mol/L sodium acetate buffer, pH 6.0,
and precursor [3H]glucosamine were run on Sephadex droitinase ABC as well as for Hdase. These studies were
therefore repeated with hyaluronate lyase (Hlyase), anG-50 spin columns. Molecules .50 kD were run through
in fractions 4 through 8 (early fractions), whereas mole- enzyme that specifically cleaves HA at the N-acetyl-b-
glucosamide-d-glucuronic acid linkage. Since Hlyase de-cules with a size ,50 kD were collected in fractions
9 through 15 (late fractions). Free precursor label was creased crystal binding practically to the same extent as
chondroitinase and Hdase, these results suggest that HAentirely recovered in late fractions. [3H]-labeled mole-
cules isolated from cell homogenates were recovered and not CS or HS should be regarded as a candidate CBM.
predominantly in fractions 4 through 8 and thus consisted
Metabolic labeling studiesmainly of macromolecules, whereas the spent medium
contained small and large molecules. The absolute incor- Hyaluronic acid is composed of linear repeats of the
disaccharide units d-glucuronic acid (b1!3) N-acetyl-d-poration of [3H]glucosamine by cells in subconfluent and
confluent cultures was, respectively, 1.5 and 9.6% of ap- glucosamine (b1!4). To study the possible involvement
of HA in crystal binding more in detail, we subsequentlyplied radioactivity.
metabolically labeled the cells with glucosamine to moni-
Crystal binding to plastic surfaces precoated with HA tor the enzymatic removal of HA fragments. Double-
label experiments were performed using [3H]glucosamineThe wells of 24-well tissue cell culture cluster plates
(Corning Costar) were coated with HA (bovine trachea; and [14C]COM, to study the relationship between HA
release and crystal adherence. Cells were exposed forSigma-Aldrich Chemie) by adding 0.5 mL/well of a solu-
tion containing increasing amounts of HA in PBS and one hour to Hdase (25 U/mL) to obtain maximal cleav-
age of [3H]glucosamine-labeled oligosaccharides from theincubating the plate at 48C overnight. Unbound HA was
removed by extensive washing with PBS, and nonspecific cell surface. Whereas the majority of the spontaneously
released glycoconjugates from untreated controls wasbinding sites were blocked with 1 mL 1% BSA (Frac-
tion V; Sigma). Approximately 150 mg [14C]COM crystals .50 kD, more than 90% of those cleaved by Hdase ap-
peared to be ,50 kD (data not shown), which is in agree-were then added to the well in a final volume of 0.5 mL.
After an incubation period of 30 minutes, all nonadhered ment with the enzymatic cleavage of HA into short oligo-
Fig. 1. (Left) Confocal microscopic image of
calcium oxalate monohydrate (COM) crystal
binding to Madin Darby canine kidney (MDCK)
cells. COM crystals were applied at the apical
side of subconfluent (A) and confluent cultures
(B) and were incubated for one hour, after
which all nonadhered particles were washed out.
In cross-sectional xz-scans perpendicular to the
cell layer, the COM crystals were detected by
light reflection (red), whereas the cells were
visualized with FITC-phalloidin-labeled F-actin
(green). Crystals (arrows) were found to adhere
to the surface of undifferentiated proliferating
cells (A), but not to the surface of maturated
growth-arrested cells (B; bar 5 10 mm).
Verkoelen et al: Hyaluronan is a crystal-binding molecule 1049
Table 1. Effect of glycosaminoglycan (GAG)-degrading enzymes with HA. These studies showed that crystals did indeed
on calcium oxalate monohydrate (COM) binding expressed in
bind to a surface that is covered by a thin layer of HA,mg/cm2 to proliferating MDCK cells (two days postseeding)
in subconfluent cultures compared to untreated controls whereas there was hardly any binding to uncoated wells
(Fig. 3A). Crystal binding to wells coated with increasingCOM binding
concentrations HA, ranging from 0 to 5000 mg/mL, waslg/cm2
linear up to 500 mg/mL. Treatment with hyaluronidaseControl 7.0960.92
Hyaluronidase 2.6460.15a of plastic wells coated with 500 mg/mL HA reduced the
Hyaluronate lyase 3.1660.09a level of crystal binding to the low levels observed in theChondroitinase ABC 2.2360.09a
absence of HA (Fig. 3B).Heparinase III 7.4560.24
a Significantly decreased compared to untreated controls (paired Student’s
Expression of hyaluronan at the surface of cells int-test, P , 0.001)
subconfluent cultures
These described results are all in agreement with the
concept that HA is a receptor for crystals. If so, onesaccharides. Expressed per cell, comparable amounts of
would expect HA to be present at the surface of COMradiolabeled molecules were released spontaneously
crystal-attracting cells but not at the surface of cells with-into the apical fluid by subconfluent and confluent un-
out affinity for crystals. Confocal microscopy (CSLM)treated cultures (Fig. 2A). Hdase cleaved approximately
images clearly demonstrated the presence of HA at the2.5-fold more radiolabeled saccharides from two-day-old
surface of MDCK cells in subconfluent cultures (Fig.subconfluent cultures than from seven-day-old confluent
4A), unless the cells were pretreated with Hdase (Fig.monolayers (Fig. 2A). In fact, Hdase treatment hardly
4B). However, HA could not be detected at the surfacecontributed to the amount of label that was extruded by
of differentiated cells, seven-days postseeding (Fig. 4C).confluent monolayers, seven days postseeding. Figure
Also, treatment of subconfluent cultures with chondroi-2B illustrates the effect of enzyme treatment on crystal
tinase abrogated the ability of FITC-bHABP to becomebinding in the same cultures that are depicted in Figure
associated with the cell surface, confirming the sensitivity2A. Treatment with Hdase of cells in subconfluent cul-
of HA for this enzyme (data not shown).tures reduced the level of crystal binding by approxi-
mately 50%, whereas the enzyme did not reduce the
Crystal binding to hyaluronan during repairalready low level of binding to functional monolayers
Finally, we studied the possibility that the enhancedfurther (Fig. 2B).
susceptibility of the cells for crystal binding during wound
Crystal binding to plastic wells coated with hyaluronan healing is mediated by surface exposed HA. Confluent
monolayers were mechanically damaged by the removalTo explore whether COM crystals can actually physi-
of approximately 30% of the cells from the growth sub-cally bind to surface exposed HA, we studied the adher-
ence of [14C]crystals to plastic wells that were precoated strates. We reported earlier that during one to three days
b
Fig. 4. (Opposite page, middle panels) Presence or absence of HA at the surface of MDCK cells in subconfluent and confluent cultures was
studied by confocal microscopy using biotinylated hyaluronan-binding protein (bHABP) after coupling to avidin-FITC (green). The location of
the cells in the cultures was visualized by counterstaining the nuclei with propidiumiodide (red). FITC-bHABP was found abundantly attached
to the surface of undifferentiated (crystal binding) cells in subconfluent cultures (A; two days postseeding), which could be avoided by pretreating
the cultures with hyaluronidase (B). HABP either did not or only hardly attached to the surface of differentiated (noncrystal binding) cells in
confluent monolayers (C, seven days postseeding; bar 5 10 mm).
b
Fig. 5. (Opposite page, bottom panels) Location of bHABP, visualized by confocal microscopy after coupling bHABP to FITC, at the surface
of MDCK cells during their recovery from mechanically inflicted wounds. The top (horizontal) pictures are hematoxyline-stained light microscopical
images (LM) of cultures directly after damaging intact monolayers “0” and during the wound healing process one, two, and four days postinjury.
Directly after the removal of cell strips with the tip of a pipette “0,” there is a clear sharp wound edge. Day 1, the cells are proliferating and
migrating from the wound border into the denuded areas. Day 2, the denuded areas are re-epithelialized and scars are formed at sites where the
wounds were closed. Day 4, the scars have disappeared, and the barrier integrity is re-established as assessed by TER measurements [9]. The
cultures resemble monolayers that were never damaged (bar 5 1 mm). Subsequently, we studied the expression of HA during wound healing
with HABP by confocal microscopy (CLSM). The squares in the LM images are representative for the areas that were analyzed during wound
healing by CLSM, in which cell nuclei were visualized with propidiumiodide (red) and HA with avidin-FITC labeled bHABP (green). At day 0,
the sharp wound edge is shown. HA is not expressed by cells in the damaged cultures, “0.” At one day postinjury, HA is found at the surface of
the flattened proliferating and migrating cells at the border of the wound “1,” whereas one day later (two days postinjury), HA is expressed by
cells that temporary formed a scar at sites where wounds were closed, “2.” Four days after damaging the cultures, bHABP binding is no longer
observed anywhere in the re-established epithelium, “4.” It should be emphasized that the cells that are expressing HA at their surface in the
present study are the same cells that previously were found to be susceptible to crystal binding [9]. Bars 5 10 mm.
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Fig. 2. Removal of [3H]glucosamine-labeled
glycoconjugates (A) with hyaluronidase from
the surface of MDCK cells in subconfluent (2
days postseeding) and confluent cultures (7 days
postseeding) and its effect on [14C]COM crys-
tal binding (B). Symbols are (j) untreated con-
trols; (h) hyaluronidase treated cultures. All
depicted bars are the means 6 SD of three
independent inserts of a representative experi-
ment that was repeated at least three times.
When expressed per cell, comparable amounts
of radiolabeled glycoconjugates were extruded
spontaneously at two and seven days post-
seeding (A, j). Haluronidase cleaved signifi-
cantly more radioactively labeled material
from the surface of cells in subconfluent cul-
tures than from cells in confluent monolayers,
*P , 0.01 as analyzed with Student’s t-test
(A, h). The level of [14C]COM crystal binding
is much higher to proliferating cells in subcon-
fluent cultures than to growth-arrested cells
in confluent cultures (B, j). Treatment of the
cells with hyaluronidase significantly reduced
the adherence of crystals to undifferentiated
cells in subconfluent cultures (**P 5 0.013
analyzed by Student’s t-test), whereas the en-
zyme did not affect the already low levels of
crystal binding observed to differentiated cells
in confluent cultures (B, h). These results
clearly demonstrate that hyaluronidase-sensi-
tive crystal-binding molecules (CBMs) are ex-
pressed at the surface of proliferating undif-
ferentiated cells, but not on the surface of
differentiated cells in an intact epithelium.
postinjury, crystals can adhere to cells that are migrating not shown). Directly after removing cell strips from con-
and proliferating in order to close the wounds [9]. The fluent cultures, bHABP could not bind to the cells at
results obtained from [14C]COM crystal-binding studies the edge of the wound (Fig. 5). Although occasional
with GAG-degrading enzyme-treated healing cultures binding was observed to the growth substrate from which
were comparable to those obtained with cells in subcon- cells were scraped, these binding patterns were rather
fluent cultures. The only remarkable difference was that vague (data not shown). One day postinjury, HA was
HA degradation resulted in a much more complete re- found to be associated with the surface of flattened cells
duction of crystal binding capacity in wounded cultures at the border of the wound (Fig. 5). At two days postin-
than in subconfluent cultures (Tables 1 and 2). This sug- jury, HA was expressed at the surface of cells in the
gests that crystals adhere exclusively to cell surface-asso- center of the healing wounds and at the surface of cells
ciated HA in wounded cultures, whereas other types of that formed a scar at sites where the wounds were closed
CBMs are also present at the surface of cells in subcon- (Fig. 5). At four days postinjury, the epithelium had
fluent cultures. completely re-established its functionality, and bHABP
could no longer or only sparsely bind to the cells in the
Cell surface expression of hyaluronan during monolayer (Fig. 5).
wound healing
Intact MDCK-I monolayers were mechanically injured
DISCUSSIONand were allowed to recover in time [light microscopical
Glycosaminoglycans such as CS and HS are presentimages (LM); Fig. 5]. To demonstrate that HA is indeed
at the cell surface as the polysaccharide side chains ofexpressed at the surface of MDCK cells during wound
cell surface-associated proteoglycans. Because of theirhealing, confocal microscopy images of FITC-bHABP
negative charge and known affinity for calcium crystals,binding were made for a period of zero to four days
these polysaccharides have often been proposed as can-after injury. HA was found to be present in the cross-
didate CBMs. A potential role for HA in crystal–cell in-shaped re-epithelialized zones, but could not be detected
teraction was largely ignored, possibly because this non-in undamaged areas within the same cultures. bHABP
was unable to adhere to bare growth substrates (data sulfated GAG is not incorporated into proteoglycans nor
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Fig. 3. Affinity of hyaluronic acid (HA) mole-
cules for calcium oxalate monohydrate (COM)
crystals was investigated by measuring the bind-
ing of [14C]COM crystals (70 mg) to the surface
of plastic wells that were coated with increas-
ing concentrations of HA (ranging from 0 to
5000 mg/mL). A linear relationship was found
between the amount of radiolabeled crystals
that were able to adhere and the HA concen-
trations used to coat the wells. Maximal bind-
ing was observed to wells coated with approxi-
mately 500 mg HA/mL (A, d). Prior to the
addition of the crystals, the HA-coated wells
were washed extensively with bovine serum
albumin (BSA; s)-containing PBS to cover
all nonspecific binding sites. Crystals were
practically unable to become associated with
wells treated only with PBS/BSA. It is shown
that the adherence of the crystals to HA (500
mg/mL) precoated wells could be prevented by
treating HA-coated wells with Hdase shortly
before the addition of [14C]COM (B), indicat-
ing that COM crystals become specifically as-
sociated with HA. A representative experi-
ment in which the means 6 SD are given of
three independent measurements. *[14C]COM
binding to HA-coated wells is significantly
higher than to uncoated wells, and **binding
to HA-coated wells treated with Hdase is sig-
nificantly reduced when compared with HA-
coated wells, analyzed with Student’s t-test.
Table 2. Effect of hyaluronidases on COM binding expressed in zyme that hydrolyzes HA but not CS [13]. The effect of
mg/cm2 to migrating and proliferating MDCK cells during wound
Hlyase on crystal binding was comparable to that ob-healing (two days postinjury) compared to untreated controls
tained with Hdase and chondroitinase ABC (Table 1).
COM binding Although these results do not completely rule out a rolelg/cm2
for CS in crystal binding, they favor HA as potential cell
Control 0.5660.23
surface-associated CBM.Wound 2.6860.16a
Wound 1 hyaluronate lyase 0.7160.07 This idea was further supported by studies in which
a Significantly increased compared to untreated controls (paired Student’s the effect of Hdase on the release of metabolically
t-test, P , 0.001) ([3H]glucosamine) labeled cell surface-associated glyco-
conjugates was compared with the effect of this enzyme
on crystal binding. These studies showed that the surface
of subconfluent MDCK-I cultures contained much higheris it a common constituent of the epithelial cell surface.
amounts of Hdase-cleavable material than that of con-Nevertheless, our results clearly identify HA as CBM at
fluent monolayers. In addition, Hdase significantly re-the surface of proliferating and migrating MDCK-I cells.
duced crystal binding to subconfluent cultures, whereasCrystal-binding studies showed that the adherence
it did not affect the already low levels of binding to intactof COM crystals is decreased by chondroitinase ABC,
monolayers. Hdase and Hlyase also significantly reducedHdase, and Hlyase, but not by heparinase III. These
crystal binding to cells in areas that were recoveringobservations seem to deny a role for HS in crystal bind-
from mechanically inflicted wounds. Hence, cell surface-ing, whereas they open up the possibility that cell surface-
associated HA seems to bind crystals in subconfluentassociated CS and HA are involved in this process. It
cultures as well as during wound healing. As proposedshould be emphasized, however, that chondroitinase ABC
earlier, the identification of a cell surface molecule asis not CS specific [12], but also degrades HA. It is also
CBM requires that first crystals bind in the presence ofknown that HA and CS are both substrates for Hdase.
the CBM. Second, crystals do not bind in the absence ofResults obtained with chondroitinase ABC and Hdase
the CBM, and third, crystals must be capable to actuallytherefore do not permit the conclusion that crystals are
interact physically with the CBM in question [14]. Theattracted by either CS or HA. To deal with this problem,
first two criteria were satisfactorily answered by ourthe crystal-binding experiments were repeated with an-
other hyaluronidase, hyaluronate lyase (Hlyase), an en- [14C]crystal-binding studies and by confocal microscopy
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images with FITC-labeled HABP, because these studies but not at basal or lateral sites, suggesting that HA is
synthesized only at the apical plasma membrane of de-clearly showed that HA is involved in binding and is
expressed by crystal-attracting cells in subconfluent cul- veloping MDCK cells. The catabolism of HA is accom-
plished by receptor-mediated endocytosis and lysosomaltures, but not by noncrystal adherent cells in functional
monolayers. The third criterion was answered by the degradation [16]. Hence, an enhanced synthesis of HA
by renal tubular cells does not necessarily lead to higheradherence of [14C]COM to HA immobilized on a plastic
surface that normally has no affinity for the crystals. This amounts of this GAG in urine. As far as we know, there
are no available data about the expression of HA inwas strengthened by the observation that binding could
be prevented by pretreating the HA-coated wells with renal tubules of stone-forming individuals.
Previously, we proposed that sialic acid molecules areHdase (Fig. 3). After the identification of HA as CBM
during subconfluency, we thought that it would be inter- involved in the exposure of CBM [25]. There are indica-
tions that HA is this CBM and that terminal sialic acidesting to see whether and where HA is expressed during
the healing of wounds made in intact monolayers. Could residues indeed play a role in the retention of HA at
the surface of proliferating and migrating MDCK cellsit be that HA is expressed at those sites in wounds where
crystal adherence takes place [9]? HABP binding re- (unpublished observations).
A “response-to-injury-hypothesis” has been proposedvealed that HA is expressed selectively by dedifferenti-
ated cells in the wound and by cells in scars formed at earlier in the pathogenesis of another “tube disease,”
atherosclerosis [26]. Central to this hypothesis is the ideawound closure (Fig. 5). Indeed, previously these sites
were found to be susceptible to crystal binding [9]. More- that different risk factors somehow lead to endothelial
dysfunction. Whereas the endothelium normally providesover, the crystal-binding areas during repair were sensi-
tive to treatment with Hlyase (Table 2). Collectively, a nonadherent surface, alterations in surface properties
lead to the attachment of blood consituents and leuko-these results identify HA as the major CBM at the sur-
face of cells that are establishing or re-establishing cell– cytes and ultimately to atherosclerotic lesions. HA also
plays a role in the pathophysiology of atherosclerosiscell contact.
HA is a polyanionic high-molecular mass (105 to 106 D), where it accumulates in diffuse thickened intima, and in
atherosclerotic lesions, HA remarkably colocalizes withunbranched negatively charged GAG that is composed
of repeating disaccharides of N-acetylglucosamine and extracellular microcrystalline calcium deposits [20, 27].
Various kinds of arterial injury have been proposed ind-glucuronic acid. At neutral pH and under physiological
ion strength conditions, HA in solution behaves as a stiff- atherosclerosis, including damage caused by hypercho-
lesterolemic, immunologic, viral, chemical, and mechani-ened random coil because of mutual electrostatic repul-
sion between carboxy groups and local helical structures cal factors. Some of these factors may also contribute to
the assumed damage to kidney cells in nephrolithiasis.stabilized by hydrogen bonding [15, 16]. This polysaccha-
ride is an integral part of extracellular matrix (ECM) In any case, the exposure of HA molecules at the luminal
side of the epithelium, as a response to epithelial injury,and pericellular matrix (PCM), where it primarily serves
as backbone for the organization of proteoglycans and/or could be responsible for the retention of crystals in the
kidney.other matrix molecules [16–18]. HA is also involved in
several fundamental cell biological processes such as de- It cannot be excluded that the adherence of crystals
to PCM only plays a role in tissue culture. It is thereforevelopment [16–18], proliferation [19], migration [20], dif-
ferentiation [16–18], metastasis [21], inflammation [21, 22] relevant to question whether there are clinical indica-
tions supporting the idea that crystals are retained inand wound healing [20–23]. During development or re-
pair, migrating cells produce large amounts of HA the kidney by associating with an HA-enriched PCM.
Although HA constitutes only a minor portion of the[20–23]. The expression of HA by epithelial cells should
therefore be regarded as an exceptional event indicative total urinary GAGs, it was found more than once that
HA is the major polysaccharide component of the or-for triggered enhanced cell motility, for example, as a
response to epithelial injury. Although HA is the only ganic kidney stone matrix [28–30]. This is in agreement
with the idea that somewhere along the urinary tractGAG with affinity for HABP, ECM proteins such as
laminin, fibronectin, and collagen also seem to have some stone crystals become associated with this polysaccha-
ride. Also, other investigators proposed a possible roleaffinity for HABP [24], which might explain the modest
staining observed in the denuded areas directly after for HA in urolithiasis. In one study, it was found that
HA promotes crystal aggregation, which according toscraping. HA is synthesized at the plasma membrane in
which specific HA synthases add sugar residues to the these authors, could explain the incorporation of HA
into stones [31]. In another more recent study, it wasreducing end of the polymer, which is translocated into
the pericellular space as a growing polysaccharide with suggested that HA might participate in one or more
stages of renal stone formation. These authors proposedthe nonreducing end ahead [16]. In our studies, HA was
found at the luminal surface of crystal-attracting cells that the multiple roles attributable to HA in renal stone
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